not used title
not used title
The 2020 election provided much-needed clarity on the issues that matter most to Americans. Here are three key takeaways:
- After months of tracking the issues one thing is now clear: Americans went to the ballot box (or their mailbox) to send a message about leadership on COVID-19 and the economy. In our election night survey conducted with Public Opinion Strategies, 43% selected the economy and 33% selected coronavirus as one of the top two issues affecting their vote. Other public election polls identified these as the top two issues as well. Partisan differences on the top voting issue were stark. Biden voters were much more likely to select coronavirus as a key issue compared to Trump voters (57% to 8%), whereas roughly three-quarters (74%) of Trump voters selected the economy compared to just 14% of Democrats. Race relations was the #2 issue for Democrats at 37% compared to just 4% of Republicans who selected this item.
- Health care (outside of COVID-19) was not a key driver of the vote this year, but it was important to many voters. Three issues stood out:
- Protecting pre-existing conditions: A bipartisan consensus emerged this year that pre-existing conditions should be protected and not overturned. Support on this issue increased across the board this year, to 79%, and Republican support jumping 19 points to 67%, according to Kaiser Family Foundation’s October tracking. Our own election night polling found the issue leading the way among health care issues at 26%, followed by coverage-related health care costs.
-
- Rising out-of-pocket costs and declining health coverage: These related issues were at the top of most polls this year, including on election night. Our election night poll found the cost of coverage in a top tier with pre-existing conditions, including the cost of premiums (18%) and out-of-pocket costs not covered by health insurance such as as co-pays and deductibles (15%). Anxieties over affordability are rooted in consumers bearing more of their health care costs. More than four in ten (41%) Americans in our Morning Consult tracking poll from November said they pay more for their health care now than they did four years ago. This plays out in voters’ biggest concerns around affordability. The Morning Consult poll further showed voters are most worried about not being able to afford out-of-pocket costs to pay for hospital bills (61%), not having the coverage they need to afford major medical expenses (60%) and going into debt because of medical expenses (58%).
-
- Prescription drug affordability was a narrower electoral issue this year, and it sits within the larger insurance coverage conversation: Because Americans with insurance coverage pay significantly more out-of-pocket for prescription medicines than for other health services. And for some, it is a key voting issue. Eight percent of voters in our election night poll said that “the cost of prescription medicines” was the most important issue in health care and only 2% said it was the top issue affecting their vote.
- Looking to the next Congress, what is clear is that voters want policymakers to address COVID-19 and their existing concerns around pre-existing conditions and out-of-pocket costs. Among the top four issues most important for policymakers to address are stopping the spread of COVID-19 (among 30% of voters’ top two issues), as well as developing and distributing a COVID-19 vaccine (20%), making health insurance more affordable (26%) and protecting patients with pre-existing conditions (17%), according to our November Morning Consult issue tracking.
The biopharmaceutical industry continues to play a critical role in these areas, leading efforts to address COVID-19 and working to ensure that Americans can access and afford the care and treatment they need. And PhRMA remains committed to advocating for effective policies that advance solutions to these clear needs.
Tom Wilbur
Tom Wilbur is Deputy Vice President of Public Affairs at PhRMA where he leads the state public affairs team and Voters for Cures, PhRMA’s grassroots advocacy initiative. Prior to joining PhRMA in 2019, Tom served as a senior aide on Capitol Hill for U.S. Rep. Fred Upton and the House Energy and Commerce Committee. Tom holds an M.A. in strategic communications from Michigan State University and a B.A. in social science and history from Central Michigan University. He enjoys spending time with family and friends, volunteering, reading and golfing.
Author Twitter
Author LinkedIn
Survey confirms too many insured Americans face barriers to reliable health care
April 22, 2026
Americans believe U.S. pharma leadership needs to be protected
February 26, 2026
50-state poll says Americans are concerned that hospital markups hurt patients
January 27, 2026
Health care practitioners sound the alarm on middlemen-imposed barriers to patient care, need for policy change
March 13, 2025
Reimagining patient access through meaningful policy reform
November 5, 2024
New PES survey: Out-of-pocket costs lead key health care priorities ahead of the November election
October 30, 2024
Americans speak out on health insurance barriers and need for policy change, according to the latest Patient Experience Survey
October 28, 2024
Where voters stand ahead of the election
October 16, 2024
Key voter insights two months from Election Day
September 10, 2024
Don’t put the government between patients and their medicines
August 7, 2024
Voters across all 50 states want state policymakers to focus on health insurance and PBM practices
July 30, 2024
New 50-state poll Americans want to hold health insurers and PBMs accountable for high out-of-pocket costs and other practices
July 9, 2024
The IRA could lead to higher out-of-pocket costs for 3.5 million Medicare patients in 2026
June 25, 2024
ICYMI: What patients care about this election year
June 24, 2024
Key election year voter insights
June 6, 2024
Ongoing federal probes shed light on PBM and insurer practices
May 20, 2024
WTAS: The consequences of consolidation and vertical integration
May 6, 2024
Insurance data: PBM reform has no material impact on premiums
April 24, 2024
ICYMI: Voter priorities this election season
April 18, 2024
Voter insights: Four things to know
March 7, 2024
Four years later, Maryland board still hasn’t delivered for patients
February 12, 2024
Setting the Record Straight: Comparing U.S. drug prices to those in foreign countries hurts patients
February 7, 2024
New poll: Americans agree that expanding the TRIPS waiver will harm U.S. global manufacturing and innovation leadership
January 29, 2024
ICYMI: When middlemen get in the way, it’s the patients who lose
December 5, 2023
WHO Pandemic Agreement offers opportunities and risks for American innovators
November 20, 2023
ICYMI: WSJ — Same Drug, Two Prices: Why the Higher Price Prevails
November 15, 2023
One year to Election Day: Four voter priorities to watch
November 6, 2023
ICYMI: Scott LaGanga and Matt Salo deliver a State of the Industry Report
October 25, 2023
New poll shows strong bipartisan support for PBM reform
October 20, 2023
What you should know about protecting your health this fall
October 16, 2023
ICYMI: Government watchdog report finds patients in Medicare Part D paid billions more for medicines than insurers and PBMs
September 28, 2023
Medicare Prescription Payment Plan will benefit patients if implemented correctly
September 21, 2023
What you need to know: COVID-19 public health emergency is over, but ideological attacks on IP remain
September 12, 2023
New PhRMA ad exposes yet another way PBMs get between patients and their medicines
September 5, 2023
Navigating the Patient Experience Survey: Protecting Lifelines to Access and Innovation
July 26, 2023
Three things to know from the latest Patient Experience Survey
July 20, 2023
Key considerations as Congress works towards PAHPA reauthorization
July 12, 2023
A conversation with Dr. Mike Ybarra on the current state of COVID-19
June 27, 2023
ICYMI: PBM exec admits choosing profits over patients
June 2, 2023
4 key facts on medicine prices and spending
May 9, 2023
4 Things to know about PhRMA’s new 50-state poll
May 4, 2023
Americans want state policymakers to lower out-of-pocket costs
May 1, 2023
Three facts about health care spending
April 25, 2023
What they are saying: Experts reinforce that TRIPS waiver expansion is harmful and unnecessary
April 13, 2023
States can support access to medicine as COVID-19 Public Health Emergency ends
April 5, 2023
Arkansas puts patients first with new share the savings law
April 4, 2023
PhRMA provides comments and testimony to USITC investigation on COVID-19 medicines and the TRIPS Agreement
March 30, 2023
Key Trends: Patient experience data reveal how insurers and middlemen impose barriers in health care
March 29, 2023
Celebrating the success of the COVID-19 vaccines, and looking to the future
March 27, 2023
PhRMA submits comments to OSTP on enhancing clinical trial diversity
March 21, 2023
What we’ve learned from three years of fighting COVID-19
March 20, 2023
Holding pharmacy benefit managers accountable
February 23, 2023
Stopping pharmacy benefit managers from “gaming the system”
February 22, 2023
Senate hearing to examine bipartisan reforms to rein in middlemen
February 16, 2023
Minnesota lawmakers are letting PBMs off the hook, and threatening patients’ access to medicines
January 31, 2023
U.S. must address IP and market access barriers abroad to protect American innovation
January 31, 2023
ICYMI: PhRMA kicks off the year at the 2023 J.P. Morgan Health Care Conference
January 19, 2023
In their own words: Insured Americans support policy reforms that address access and affordability concerns
December 14, 2022
In their own words: Financial barriers exacerbate access challenges for insured Americans
December 8, 2022
Word of the Month: What is TRIPS?
November 29, 2022
Putting Delaware patients first: Protecting Patient Assistance Programs
November 22, 2022
New data show how insurers and middlemen shift Rx costs onto patients
November 16, 2022
TRIPS waiver expansion risks public health
November 14, 2022
Expanding the WTO intellectual property waiver will hurt American jobs
November 9, 2022
In their own words: Insured Americans struggle to navigate complex coverage
October 26, 2022
Word of the Month: Long COVID
October 19, 2022
Many seniors are paying more for Part D medicines than their insurer
October 18, 2022
Protecting against influenza: A conversation with David Ross, Vice President, Commercial Operations, North America, CSL Seqirus
October 13, 2022
New comments outline ways to protect patients from health plans and PBMs who profit from patient assistance
October 7, 2022
Busting 3 Myths About Copay Coupons
October 5, 2022
Mental Illness Awareness Week – A time for reflection
October 3, 2022
A key fact the White House is reluctant to admit
September 27, 2022
A key fact the White House is reluctant to admit
September 27, 2022
Partnerships are driving global COVID-19 treatment access
September 22, 2022
The dangers of expanding the TRIPS waiver
September 19, 2022
Navigating the patient experience: Burdens and barriers standing between patients and their care
September 12, 2022
Making coupons count for patients at the pharmacy counter
August 25, 2022
ICYMI: New research builds upon growing body of evidence on value of COVID-19 treatments and vaccines
August 16, 2022
New survey: Voters seriously concerned about fine print in reconciliation bill
August 12, 2022
Making coupons count for patients with HIV
August 8, 2022
The Senate’s latest price setting proposal will undermine: Our health care system
July 28, 2022
The Senate’s latest price setting proposal will undermine: Patient access to medicines
July 26, 2022
Survey Says: Prescription drug prices are not fueling inflation concerns for Americans
July 22, 2022
ICYMI: PhRMA’s Ubl pens op-ed on IP waiver for COVID-19 technologies
July 15, 2022
Increase in drug-resistant superbugs during COVID-19 highlights need for policy reforms to address antimicrobial resistance
July 14, 2022
Putting patients first at the state level — A conversation with Mark Reisenauer, President of Astellas Pharma US
July 14, 2022
Polling continues to show voters reject so-called Medicare “negotiation” once they learn about consequences for patients
July 12, 2022
Patients win as West Virginia implements first-in-nation share the savings policy
July 8, 2022
3 things voters are concerned about when it comes to their health care coverage
July 7, 2022
COVID-19 vaccines and treatments helped save millions of lives and billions in health care costs
July 7, 2022
ICYMI: Antimicrobial resistance spotlighted as growing public health threat
July 6, 2022
Copay assistance is a lifeline for patients. So why are insurers blocking it?
June 29, 2022
Patients support state action requiring PBMs and insurers to share savings and cap costs for medicines
June 16, 2022
New poll shows voters sounding the alarm on health insurance companies and PBMs
June 6, 2022
PhRMA warns of the growing influence of middlemen over patient access and out-of-pocket costs for patients
May 31, 2022
Intellectual Property waiver on COVID-19 innovation is unnecessary and harmful
May 23, 2022
ICYMI: PhRMA CEO Stephen J. Ubl spotlights lessons learned during COVID-19
May 13, 2022
ICYMI: PhRMA COO Lori Reilly spotlights efforts to improve health care in 2022 and beyond
May 9, 2022
A conversation with Barry Greene, CEO of Sage Therapeutics
May 4, 2022
Study finds insurance barriers disproportionately burden patients with chronic illness
May 4, 2022
ICYMI: New resource catalogs biopharmaceutical industry lessons learned from COVID-19
April 28, 2022
What’s really happening when it comes to prescription drug costs
April 27, 2022
5 public opinion polling trends to watch
April 22, 2022
Analysis: States can help patients save nearly $1,000 annually on their medicines
April 21, 2022
New analysis confirms hospitals markup prices for oncology therapies
April 21, 2022
How standardized plans can improve patients’ access to medicines
April 18, 2022
The patient experience: Uncovering the barriers to care for insured Americans
March 28, 2022
Correcting the record: Putting medicine costs and spending in context
March 24, 2022
Sharing rebates can save Americans with diabetes 500 each year and improve adherence
March 16, 2022
If drug prices are growing below the rate of inflation, why are patients still feeling the sting at the pharmacy?
March 8, 2022
The patient experience: Insurance barriers continue to impede access to health care, especially among the country’s underserved
February 28, 2022
New Data: COVID-19 vaccine global production capacity projected to exceed 20 billion doses this year
February 24, 2022
What you need to know about newly authorized COVID-19 antiviral treatments
February 22, 2022
Guest post: Joining forces to combat the COVID-19 mental health crisis
February 17, 2022
Guest Blog: COVID-19 vaccines are the key to keeping kids healthy
February 16, 2022
Medicaid 101: Three charts on access and spending
February 3, 2022
Government price setting won’t stop insurers from shifting costs to patients
February 2, 2022
Protecting U.S. innovation abroad to support economic and pandemic recovery
February 1, 2022
New comments outline ways to counteract cost-shifting insurance trends
January 28, 2022
Patients need to pay less for their medicines. States can help.
January 26, 2022
It’s a new year, but sadly Congress is still pursuing flawed price setting policies
January 25, 2022
New poll of all 50 states and 435 Congressional Districts shows perils of so-called Medicare “negotiation”
January 25, 2022
ICYMI: New report demonstrates growing global impact of antimicrobial resistance
January 24, 2022
New study finds more than half of brand medicine spending goes to the supply chain and others
January 7, 2022
Making medicines more affordable: Making insurance work like insurance
December 8, 2021
Navigating the patient experience in the time of COVID-19
December 6, 2021
Global COVID-19 vaccination matters now and for the future
November 29, 2021
Insurance design barriers can impact patient adherence and can lead to poor health outcomes
November 23, 2021
What is missing in the current drug pricing plan
November 23, 2021
ICYMI: PhRMA CEO speaks at STAT Summit about government price setting
November 19, 2021
Making medicines more affordable: Sharing savings at the pharmacy counter
November 19, 2021
Three things to know about so-called Medicare negotiation polling
November 18, 2021
Understanding breakthrough COVID-19 infections
November 11, 2021
Making Medicines More Affordable: Making coupons count
November 5, 2021
What they are saying: Government price setting for medicines is not the answer
November 4, 2021
PhRMA submission to 2022 National Trade Estimate Report underscores need for pro-innovation U.S. trade policy to combat COVID-19
October 29, 2021
Four things to know from IQVIAs latest report
October 29, 2021
The patient experience: Insurance design hurdles lead to access issues for too many Americans
October 28, 2021
The patient experience: Out-of-pocket costs are driving patients affordability and access challenges
October 19, 2021
New poll shows Americans reject Medicare negotiation once they learn more about the policy
October 15, 2021
What is Kaiser Family Foundation up to?
October 12, 2021
New report shows 3 in 10 Americans that have insurance still face a financial barrier to care
October 7, 2021
The important role of antivirals in the fight against COVID-19
October 6, 2021
Understanding Long COVID-19
September 29, 2021
Industry leaders discuss the impact of the drug pricing debate
September 23, 2021
Five reasons tying VA prices to Medicare Part D misses the mark
September 22, 2021
America’s biopharmaceutical companies to Congress: Government “negotiation” is the wrong approach
September 15, 2021
A year and a half later: The biopharmaceutical industry remains committed to beating COVID-19
September 8, 2021
The impact of monoclonal antibodies and COVID-19 recovery
September 2, 2021
Recognizing National Immunization Awareness Month
August 31, 2021
Recent polling misrepresents public support for Medicare “negotiation”
August 31, 2021
Driving further innovation is critical to global vaccine equity
August 24, 2021
Myth vs. fact: Polling and Medicare “negotiation”
August 12, 2021
Supporting country readiness to boost global vaccine access
August 12, 2021
Ensuring global vaccine equity requires eliminating trade and regulatory barriers
August 5, 2021
ICYMI: Event spotlights how we can make Medicare work better for patients
August 4, 2021
Setting the record straight: Addressing common misconceptions about the COVID-19 vaccine
August 4, 2021
The future of the rebate rule: Will policymakers stand with patients?
August 2, 2021
Celebrating Medicare’s 56th anniversary
July 30, 2021
Increasing global access to vaccines by optimizing production
July 29, 2021
Guest post: Retired medics return to the field to take on vaccine delivery and disaster relief
July 23, 2021
Guest Post: A patient’s story of the long-term health impacts of COVID-19
July 21, 2021
3 factors impacting medication adherence for patients with diabetes
July 20, 2021
Dose sharing as a part of the COVID-19 global vaccine equity strategy
July 20, 2021
Promoting global vaccine equity while protecting innovation
July 15, 2021
Data shows voters strongly support protecting access to their medicines
July 15, 2021
Data shows COVID-19 vaccines are creating a pathway to a strong U.S. recovery
July 2, 2021
PhRMA awards $75,000 to fund initiatives to reduce health inequities
July 1, 2021
More than 800 medicines are in development for diseases that disproportionately affect racial and ethnic communities
June 22, 2021
Americans 12 years of age and older are eligible for COVID-19 vaccines
June 17, 2021
PhRMA hosts first stakeholder workshop on clinical trial diversity
June 11, 2021
Coming together to fight COVID-19: A conversation with Barry Greene, CEO of Sage Therapeutics
June 9, 2021
New reports shed light on key facts about medicines and affordability
June 8, 2021
A year later: Reflections on the meaning of equity
May 25, 2021
Out-of-pocket trends in Medicare Part D show rising costs for seniors
May 24, 2021
ICYMI: PhRMA president and CEO Stephen J. Ubl joins other industry leaders for a conversation on COVID-19 vaccines with Axios
May 21, 2021
Supporting India during the devastating coronavirus surge
May 20, 2021
Study finds nearly half of payers believe innovative contracts can lead to lower patient out-of-pocket costs
May 17, 2021
New polling shows Americans are sounding the alarm on the TRIPS IP waiver
May 14, 2021
The Biden Administration allows politics to upend a pragmatic pandemic response
May 14, 2021
Four solutions Americans support to make health care more affordable
May 13, 2021
PhRMA CAREs Grant request for proposals: Addressing inequities in access to COVID-19 testing, therapeutics and vaccines
May 6, 2021
Ron Busby, Sr., President and CEO of the U.S. Black Chambers, Inc. on improving vaccine confidence in community
May 5, 2021
Reflecting on Mental Health Awareness Month
May 4, 2021
American leadership on innovation policy is essential to global health progress
May 4, 2021
New data from insurers show detriments of copay accumulator adjustment programs
April 28, 2021
Patient safety is at the heart of COVID-19 vaccine R&D
April 26, 2021
Data shows that Americans are relying on vaccines to get us through the pandemic
April 22, 2021
West Virginia becomes the first state to lower patient costs by sharing the savings
April 20, 2021
ICYMI: New CBO Report highlights biopharmaceutical leadership in the development of new treatments and cures
April 12, 2021
Diversifying clinical trials and fighting disease requires equity and trust
April 12, 2021
Data shows that keeping a strong biopharmaceutical industry is important to Americans
March 30, 2021
Building confidence in the COVID-19 vaccine through education
March 22, 2021
ICYMI: WSJ showcases breakthrough science of COVID-19 vaccines and implications for future medicines
March 8, 2021
Intellectual property is the key to vaccine development, manufacturing and technology sharing
March 5, 2021
Nearly 40% of commercially insured patients face half their annual out-of-pocket expenses from just one health care encounter
March 2, 2021
Coming together to fight COVID-19: A conversation with Paul Perreault, CEO and Managing Director of CSL
February 24, 2021